ClinicalTrials.Veeva

Menu

The Occurrence of Atrial Fibrillation After Totally Endoscopic Cardiac Surgery (AFMICS-II)

J

Jessa Hospital

Status

Terminated

Conditions

Atrial Fibrillation

Treatments

Device: FibriCheck

Study type

Interventional

Funder types

Other

Identifiers

NCT05633797
f/2022/127

Details and patient eligibility

About

The aim of this study is to investigate the occurrence of new-onset postoperative atrial fibrillation after totally endoscopic cardiac surgery.

Enrollment

152 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • >18 years old
  • Patients undergoing elective endoscopic cardiac surgery (totally endoscopic coronary artery bypass grafting or endoscopic valve replacement)

Exclusion criteria

  • Preoperative atrial fibrillation
  • Patients that do not understand Dutch or French or English
  • Patients that do not have a smartphone
  • Concomitant or redo surgeries

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

152 participants in 1 patient group

Totally endoscopic cardiac surgery
Experimental group
Description:
Patients will be monitored using the FibriCheck application to detect atrial fibrillation until 30 days postoperative.
Treatment:
Device: FibriCheck

Trial contacts and locations

1

Loading...

Central trial contact

Alaaddin Yilmaz, MD; Jade Claessens, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems